[Guidelines for Therapy of Chronic Heart Failure]

Overview

Journal Z Kardiol

Specialty Cardiology & Vascular Diseases

Date 2005 Jul 29

PMID 16049651

Citations 37

Authors

U C Hoppe

M Bohm

R Dietz

P Hanrath

H K Kroemer

A Osterspey

A A Schmaltz

E Erdmann

Affiliations

Soon will be listed here.

Citing Articles

[Validation of subjective complaints: differential diagnosis of "healthy suffering" using fatigue as an example].

Linden M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024; 67(11):1264-1272.

PMID: 39400559 PMC: 11549139. DOI: 10.1007/s00103-024-03963-w.

Measuring context that matters: validation of the modular Tele-QoL patient-reported outcome and experience measure.

Greffin K, Muehlan H, Berg N, Hoffmann W, Ritter O, Oeff M Qual Life Res. 2023; 32(11):3223-3234.

PMID: 37458961 PMC: 10522723. DOI: 10.1007/s11136-023-03469-z.

Setting-Sensitive Conceptualization and Assessment of Quality of Life in Telemedical Care-Study Protocol of the Tele-QoL Project.

Greffin K, Muehlan H, Berg N, Hoffmann W, Ritter O, Oeff M Int J Environ Res Public Health. 2021; 18(19).

PMID: 34639754 PMC: 8507616. DOI: 10.3390/ijerph181910454.

[Dyspnea. From the concept up to diagnostics].

Ewert R, Glaser S Internist (Berl). 2015; 56(8):865-71.

PMID: 26078046 DOI: 10.1007/s00108-015-3690-3.

The relevance of accuracy of heartbeat perception in noncardiac and cardiac chest pain.

Schroeder S, Gerlach A, Achenbach S, Martin A Int J Behav Med. 2014; 22(2):258-67.

PMID: 25200446 DOI: 10.1007/s12529-014-9433-3.

References

. Recommendations for exercise training in chronic heart failure patients. Eur Heart J. 2001; 22(2):125-35. DOI: 10.1053/euhj.2000.2440. View

Maggioni A, Anand I, Gottlieb S, Latini R, Tognoni G, Cohn J . Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2002; 40(8):1414-21. DOI: 10.1016/s0735-1097(02)02304-5. View

Cohn J, Ziesche S, Smith R, Anand I, Dunkman W, LOEB H . Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 1997; 96(3):856-63. DOI: 10.1161/01.cir.96.3.856. View

Gandhi S, POWERS J, NOMEIR A, Fowle K, Kitzman D, Rankin K . The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001; 344(1):17-22. DOI: 10.1056/NEJM200101043440103. View

Kadish A, Dyer A, Daubert J, Quigg R, Mark Estes N, Anderson K . Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350(21):2151-8. DOI: 10.1056/NEJMoa033088. View

Eichhorn E, Domanski M, Krause-Steinrauf H, Bristow M, Lavori P . A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001; 344(22):1659-67. DOI: 10.1056/NEJM200105313442202. View

Cleland J, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar J . The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003; 24(5):442-63. DOI: 10.1016/s0195-668x(02)00823-0. View

Pfeffer M, McMurray J, Velazquez E, Rouleau J, Kober L, Maggioni A . Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003; 349(20):1893-906. DOI: 10.1056/NEJMoa032292. View

Flather M, Shibata M, Coats A, Van Veldhuisen D, Parkhomenko A, Borbola J . Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005; 26(3):215-25. DOI: 10.1093/eurheartj/ehi115. View

10.

. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83. DOI: 10.1056/NEJM199711273372202. View

11.

Gehlbach B, Geppert E . The pulmonary manifestations of left heart failure. Chest. 2004; 125(2):669-82. DOI: 10.1378/chest.125.2.669. View

12.

Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel J . Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998; 98(12):1184-91. DOI: 10.1161/01.cir.98.12.1184. View

13.

Romano M, Bolling S . Mitral valve repair as an alternative treatment for heart failure patients. Heart Fail Monit. 2003; 4(1):7-12. View

14.

Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M . Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation. 2000; 101(14):1660-4. DOI: 10.1161/01.cir.101.14.1660. View

15.

Bouvy M, Heerdink E, Leufkens H, Hoes A . Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 2003; 89(6):605-9. PMC: 1767685. DOI: 10.1136/heart.89.6.605. View

16.

Hoppe U, Erdmann E . [Guidelines for therapy of chronic heart failure. German Society of Cardiology-Heart and Cardiovascular Research]. Z Kardiol. 1998; 87(8):645-58. View

17.

Cohn J, Ferrari R, Sharpe N . Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000; 35(3):569-82. DOI: 10.1016/s0735-1097(99)00630-0. View

18.

Strickberger S, Hummel J, Bartlett T, Frumin H, Schuger C, Beau S . Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. J Am Coll Cardiol. 2003; 41(10):1707-12. DOI: 10.1016/s0735-1097(03)00297-3. View

19.

Hoppe U, Erdmann E . [Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology--Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with...]. Z Kardiol. 2001; 90(3):218-37. DOI: 10.1007/s003920170187. View

20.

Flather M, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G . Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000; 355(9215):1575-81. DOI: 10.1016/s0140-6736(00)02212-1. View